Financhill
Buy
69

VREO.CX Quote, Financials, Valuation and Earnings

Last price:
$0.84
Seasonality move :
-1.16%
Day range:
$0.74 - $0.84
52-week range:
$0.43 - $1.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.58x
P/B ratio:
2.19x
Volume:
322.2K
Avg. volume:
111.3K
1-year change:
-3.66%
Market cap:
$750.3M
Revenue:
$136.2M
EPS (TTM):
-$0.20

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
VREO.CX
Vireo Growth, Inc.
$130.5M -- 277.31% -- --
DRUG.CX
Bright Minds Biosciences, Inc.
-- -$1.00 -- -483.33% $89.67
FFNT.CX
4Front Ventures Corp.
-- -- -- -- --
GTII.CX
Green Thumb Industries, Inc.
$405.6M $0.05 -1.05% -100% $17.51
LOWL.CX
Lowell Farms, Inc.
-- -- -- -- --
WESA.X.CX
Wesana Health Holdings
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
VREO.CX
Vireo Growth, Inc.
$0.79 -- $750.3M -- $0.00 0% 1.58x
DRUG.CX
Bright Minds Biosciences, Inc.
$115.56 $89.67 $819.2M -- $0.00 0% --
FFNT.CX
4Front Ventures Corp.
$0.0050 -- $4.6M -- $0.00 0% 0.04x
GTII.CX
Green Thumb Industries, Inc.
$10.60 $17.51 $2.5B 41.09x $0.00 0% 1.55x
LOWL.CX
Lowell Farms, Inc.
$0.02 -- $272.2K -- $0.00 0% 0.01x
WESA.X.CX
Wesana Health Holdings
$0.0100 -- $200.8K -- $0.00 0% 0.39x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
VREO.CX
Vireo Growth, Inc.
45.27% -3.608 33.16% 0.56x
DRUG.CX
Bright Minds Biosciences, Inc.
0.27% 3.206 0.06% 84.94x
FFNT.CX
4Front Ventures Corp.
338.18% 2.441 156.19% 0.11x
GTII.CX
Green Thumb Industries, Inc.
22.08% 0.998 27.9% 1.19x
LOWL.CX
Lowell Farms, Inc.
-- 1.953 -- 0.35x
WESA.X.CX
Wesana Health Holdings
-- -3.241 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
VREO.CX
Vireo Growth, Inc.
$48.6M $2.2M -25.61% -52.07% 1.76% -$30.9M
DRUG.CX
Bright Minds Biosciences, Inc.
-$15.8K -$3.3M -25.1% -25.19% -- -$3.5M
FFNT.CX
4Front Ventures Corp.
$5M -$8.9M -137.74% -- -25.23% -$770.6K
GTII.CX
Green Thumb Industries, Inc.
$189.3M $50.6M 1.96% 2.53% 12.61% $78.2M
LOWL.CX
Lowell Farms, Inc.
-$1.3M -$2.9M -130.79% -182.5% -99.38% -$1.2M
WESA.X.CX
Wesana Health Holdings
-- -- -- -- -- --

Vireo Growth, Inc. vs. Competitors

  • Which has Higher Returns VREO.CX or DRUG.CX?

    Bright Minds Biosciences, Inc. has a net margin of -28.69% compared to Vireo Growth, Inc.'s net margin of --. Vireo Growth, Inc.'s return on equity of -52.07% beat Bright Minds Biosciences, Inc.'s return on equity of -25.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    VREO.CX
    Vireo Growth, Inc.
    38.51% -$0.04 $626.2M
    DRUG.CX
    Bright Minds Biosciences, Inc.
    -- -$0.74 $52M
  • What do Analysts Say About VREO.CX or DRUG.CX?

    Vireo Growth, Inc. has a consensus price target of --, signalling downside risk potential of -17.72%. On the other hand Bright Minds Biosciences, Inc. has an analysts' consensus of $89.67 which suggests that it could fall by -22.41%. Given that Bright Minds Biosciences, Inc. has more downside risk than Vireo Growth, Inc., analysts believe Vireo Growth, Inc. is more attractive than Bright Minds Biosciences, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    VREO.CX
    Vireo Growth, Inc.
    0 0 0
    DRUG.CX
    Bright Minds Biosciences, Inc.
    6 0 0
  • Is VREO.CX or DRUG.CX More Risky?

    Vireo Growth, Inc. has a beta of 0.001, which suggesting that the stock is 99.895% less volatile than S&P 500. In comparison Bright Minds Biosciences, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock VREO.CX or DRUG.CX?

    Vireo Growth, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bright Minds Biosciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vireo Growth, Inc. pays -- of its earnings as a dividend. Bright Minds Biosciences, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios VREO.CX or DRUG.CX?

    Vireo Growth, Inc. quarterly revenues are $126.2M, which are larger than Bright Minds Biosciences, Inc. quarterly revenues of --. Vireo Growth, Inc.'s net income of -$36.2M is lower than Bright Minds Biosciences, Inc.'s net income of -$5.2M. Notably, Vireo Growth, Inc.'s price-to-earnings ratio is -- while Bright Minds Biosciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vireo Growth, Inc. is 1.58x versus -- for Bright Minds Biosciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    VREO.CX
    Vireo Growth, Inc.
    1.58x -- $126.2M -$36.2M
    DRUG.CX
    Bright Minds Biosciences, Inc.
    -- -- -- -$5.2M
  • Which has Higher Returns VREO.CX or FFNT.CX?

    4Front Ventures Corp. has a net margin of -28.69% compared to Vireo Growth, Inc.'s net margin of -37.38%. Vireo Growth, Inc.'s return on equity of -52.07% beat 4Front Ventures Corp.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    VREO.CX
    Vireo Growth, Inc.
    38.51% -$0.04 $626.2M
    FFNT.CX
    4Front Ventures Corp.
    21.39% -$0.01 $27.7M
  • What do Analysts Say About VREO.CX or FFNT.CX?

    Vireo Growth, Inc. has a consensus price target of --, signalling downside risk potential of -17.72%. On the other hand 4Front Ventures Corp. has an analysts' consensus of -- which suggests that it could grow by 2907.29%. Given that 4Front Ventures Corp. has higher upside potential than Vireo Growth, Inc., analysts believe 4Front Ventures Corp. is more attractive than Vireo Growth, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    VREO.CX
    Vireo Growth, Inc.
    0 0 0
    FFNT.CX
    4Front Ventures Corp.
    0 0 0
  • Is VREO.CX or FFNT.CX More Risky?

    Vireo Growth, Inc. has a beta of 0.001, which suggesting that the stock is 99.895% less volatile than S&P 500. In comparison 4Front Ventures Corp. has a beta of 0.812, suggesting its less volatile than the S&P 500 by 18.786%.

  • Which is a Better Dividend Stock VREO.CX or FFNT.CX?

    Vireo Growth, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. 4Front Ventures Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vireo Growth, Inc. pays -- of its earnings as a dividend. 4Front Ventures Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios VREO.CX or FFNT.CX?

    Vireo Growth, Inc. quarterly revenues are $126.2M, which are larger than 4Front Ventures Corp. quarterly revenues of $23.4M. Vireo Growth, Inc.'s net income of -$36.2M is lower than 4Front Ventures Corp.'s net income of -$8.7M. Notably, Vireo Growth, Inc.'s price-to-earnings ratio is -- while 4Front Ventures Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vireo Growth, Inc. is 1.58x versus 0.04x for 4Front Ventures Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    VREO.CX
    Vireo Growth, Inc.
    1.58x -- $126.2M -$36.2M
    FFNT.CX
    4Front Ventures Corp.
    0.04x -- $23.4M -$8.7M
  • Which has Higher Returns VREO.CX or GTII.CX?

    Green Thumb Industries, Inc. has a net margin of -28.69% compared to Vireo Growth, Inc.'s net margin of 8.17%. Vireo Growth, Inc.'s return on equity of -52.07% beat Green Thumb Industries, Inc.'s return on equity of 2.53%.

    Company Gross Margin Earnings Per Share Invested Capital
    VREO.CX
    Vireo Growth, Inc.
    38.51% -$0.04 $626.2M
    GTII.CX
    Green Thumb Industries, Inc.
    47.18% $0.14 $3.3B
  • What do Analysts Say About VREO.CX or GTII.CX?

    Vireo Growth, Inc. has a consensus price target of --, signalling downside risk potential of -17.72%. On the other hand Green Thumb Industries, Inc. has an analysts' consensus of $17.51 which suggests that it could grow by 65.22%. Given that Green Thumb Industries, Inc. has higher upside potential than Vireo Growth, Inc., analysts believe Green Thumb Industries, Inc. is more attractive than Vireo Growth, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    VREO.CX
    Vireo Growth, Inc.
    0 0 0
    GTII.CX
    Green Thumb Industries, Inc.
    9 1 0
  • Is VREO.CX or GTII.CX More Risky?

    Vireo Growth, Inc. has a beta of 0.001, which suggesting that the stock is 99.895% less volatile than S&P 500. In comparison Green Thumb Industries, Inc. has a beta of 0.833, suggesting its less volatile than the S&P 500 by 16.713%.

  • Which is a Better Dividend Stock VREO.CX or GTII.CX?

    Vireo Growth, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Green Thumb Industries, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vireo Growth, Inc. pays -- of its earnings as a dividend. Green Thumb Industries, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios VREO.CX or GTII.CX?

    Vireo Growth, Inc. quarterly revenues are $126.2M, which are smaller than Green Thumb Industries, Inc. quarterly revenues of $401.3M. Vireo Growth, Inc.'s net income of -$36.2M is lower than Green Thumb Industries, Inc.'s net income of $32.8M. Notably, Vireo Growth, Inc.'s price-to-earnings ratio is -- while Green Thumb Industries, Inc.'s PE ratio is 41.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vireo Growth, Inc. is 1.58x versus 1.55x for Green Thumb Industries, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    VREO.CX
    Vireo Growth, Inc.
    1.58x -- $126.2M -$36.2M
    GTII.CX
    Green Thumb Industries, Inc.
    1.55x 41.09x $401.3M $32.8M
  • Which has Higher Returns VREO.CX or LOWL.CX?

    Lowell Farms, Inc. has a net margin of -28.69% compared to Vireo Growth, Inc.'s net margin of -111.87%. Vireo Growth, Inc.'s return on equity of -52.07% beat Lowell Farms, Inc.'s return on equity of -182.5%.

    Company Gross Margin Earnings Per Share Invested Capital
    VREO.CX
    Vireo Growth, Inc.
    38.51% -$0.04 $626.2M
    LOWL.CX
    Lowell Farms, Inc.
    -28.98% -$0.26 $5.7M
  • What do Analysts Say About VREO.CX or LOWL.CX?

    Vireo Growth, Inc. has a consensus price target of --, signalling downside risk potential of -17.72%. On the other hand Lowell Farms, Inc. has an analysts' consensus of -- which suggests that it could grow by 19875.27%. Given that Lowell Farms, Inc. has higher upside potential than Vireo Growth, Inc., analysts believe Lowell Farms, Inc. is more attractive than Vireo Growth, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    VREO.CX
    Vireo Growth, Inc.
    0 0 0
    LOWL.CX
    Lowell Farms, Inc.
    0 0 0
  • Is VREO.CX or LOWL.CX More Risky?

    Vireo Growth, Inc. has a beta of 0.001, which suggesting that the stock is 99.895% less volatile than S&P 500. In comparison Lowell Farms, Inc. has a beta of 1.815, suggesting its more volatile than the S&P 500 by 81.503%.

  • Which is a Better Dividend Stock VREO.CX or LOWL.CX?

    Vireo Growth, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lowell Farms, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vireo Growth, Inc. pays -- of its earnings as a dividend. Lowell Farms, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios VREO.CX or LOWL.CX?

    Vireo Growth, Inc. quarterly revenues are $126.2M, which are larger than Lowell Farms, Inc. quarterly revenues of $4.4M. Vireo Growth, Inc.'s net income of -$36.2M is lower than Lowell Farms, Inc.'s net income of -$5M. Notably, Vireo Growth, Inc.'s price-to-earnings ratio is -- while Lowell Farms, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vireo Growth, Inc. is 1.58x versus 0.01x for Lowell Farms, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    VREO.CX
    Vireo Growth, Inc.
    1.58x -- $126.2M -$36.2M
    LOWL.CX
    Lowell Farms, Inc.
    0.01x -- $4.4M -$5M
  • Which has Higher Returns VREO.CX or WESA.X.CX?

    Wesana Health Holdings has a net margin of -28.69% compared to Vireo Growth, Inc.'s net margin of --. Vireo Growth, Inc.'s return on equity of -52.07% beat Wesana Health Holdings's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    VREO.CX
    Vireo Growth, Inc.
    38.51% -$0.04 $626.2M
    WESA.X.CX
    Wesana Health Holdings
    -- -- --
  • What do Analysts Say About VREO.CX or WESA.X.CX?

    Vireo Growth, Inc. has a consensus price target of --, signalling downside risk potential of -17.72%. On the other hand Wesana Health Holdings has an analysts' consensus of -- which suggests that it could grow by 2383.25%. Given that Wesana Health Holdings has higher upside potential than Vireo Growth, Inc., analysts believe Wesana Health Holdings is more attractive than Vireo Growth, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    VREO.CX
    Vireo Growth, Inc.
    0 0 0
    WESA.X.CX
    Wesana Health Holdings
    0 0 0
  • Is VREO.CX or WESA.X.CX More Risky?

    Vireo Growth, Inc. has a beta of 0.001, which suggesting that the stock is 99.895% less volatile than S&P 500. In comparison Wesana Health Holdings has a beta of -1.000, suggesting its less volatile than the S&P 500 by 200.004%.

  • Which is a Better Dividend Stock VREO.CX or WESA.X.CX?

    Vireo Growth, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Wesana Health Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vireo Growth, Inc. pays -- of its earnings as a dividend. Wesana Health Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios VREO.CX or WESA.X.CX?

    Vireo Growth, Inc. quarterly revenues are $126.2M, which are larger than Wesana Health Holdings quarterly revenues of --. Vireo Growth, Inc.'s net income of -$36.2M is higher than Wesana Health Holdings's net income of --. Notably, Vireo Growth, Inc.'s price-to-earnings ratio is -- while Wesana Health Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vireo Growth, Inc. is 1.58x versus 0.39x for Wesana Health Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    VREO.CX
    Vireo Growth, Inc.
    1.58x -- $126.2M -$36.2M
    WESA.X.CX
    Wesana Health Holdings
    0.39x -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock